The relationship between augmenter of liver regeneration, cytochrome P450 and the drug resistance of induced human hepatocellular carcinoma drug-resistant cells in vitro

XU Yong-hong; et al

doi:10.13406/j.cnki.cyxb.2011.03.029

您当前的位置：

首页 >

文章列表页 >

The relationship between augmenter of liver regeneration, cytochrome P450 and the drug resistance of induced human hepatocellular carcinoma drug-resistant cells in vitro

更新时间：2024-01-17

- The relationship between augmenter of liver regeneration, cytochrome P450 and the drug resistance of induced human hepatocellular carcinoma drug-resistant cells in vitro
- Journal of Chongqing Medical University Vol. 36, Issue 3, Pages: 257-262(2011)
- 作者机构：
  
  重庆医科大学附属第二医院病毒性肝炎研究所
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2011.03.029
  CLC： R735.7
- Published：2011，
扫描看全文
[1]徐永红,孙航,郭晖,钱克莉,张臣丽,刘杞.肝再生增强因子,细胞色素P450与人肝癌细胞在体外耐药的关系[J].重庆医科大学学报,2011,36(03):257-262.

XU Yong-hong, et al. The relationship between augmenter of liver regeneration, cytochrome P450 and the drug resistance of induced human hepatocellular carcinoma drug-resistant cells in vitro. [J]. Journal of Chongqing Medical University 36(3):257-262(2011)
[1]徐永红,孙航,郭晖,钱克莉,张臣丽,刘杞.肝再生增强因子,细胞色素P450与人肝癌细胞在体外耐药的关系[J].重庆医科大学学报,2011,36(03):257-262. DOI： 10.13406/j.cnki.cyxb.2011.03.029.

XU Yong-hong, et al. The relationship between augmenter of liver regeneration, cytochrome P450 and the drug resistance of induced human hepatocellular carcinoma drug-resistant cells in vitro. [J]. Journal of Chongqing Medical University 36(3):257-262(2011) DOI： 10.13406/j.cnki.cyxb.2011.03.029.

摘要

目的:研究肝癌顺铂耐药细胞HepG2/cDDP中人肝再生增强因子（Human augmenter of liver regeneration

hALR）对细胞色素P450（Cytochrome P450

CYP450）表达的影响

观察ALR是否通过作用CYP450与肝癌细胞耐药的形成有关。方法:建立体外肝癌顺铂耐药细胞系

MTT检测耐药指数;将构建好的人肝再生增强因子siRNA表达质粒psiALR-A及其阴性对照质粒psiALR-B采用脂质体转染的方法分别转染至HepG2/cDDP细胞

荧光显微镜观察绿色荧光蛋白的表达

计算转染效率。根据转染不同的质粒

将HepG2/cDDP细胞分为3组:转染组（转染psiALR-A）

对照组（转染psiALR-B）

空白组（未转染重组质粒）。免疫细胞化学法、免疫印迹法、实时荧光定量PCR法检测转染细胞中hALR和CYP450的表达

化学发光法检测各组细胞中CYP3A4的活性

MTT比色法检测各组细胞对顺铂敏感性的变化。结果:耐药模型成功建立

耐药指数为6.26;成功转染质粒psiALR-A和psiALR-B;转染组细胞中hALR表达明显减少

CYP450的表达明显增加

活性升高

而对照组和空白组细胞中hALR和CYP450表达没有明显的变化。MTT结果显示转染组细胞对顺铂的敏感性降低

对照组和空白组细胞对顺铂的敏感性没有明显变化。结论:阻断人肝再生增强因子的表达后

HepG2/cDDP细胞CYP450表达明显增加

活性增强

对顺铂的敏感性下降

ALR可能通过作用CYP450在肝癌细胞耐药的发生发展中起着重要作用。

Abstract

Objective:To investigate the effects of augmenter of liver regeneration(hALR) in cisplatin(cDDP) induced human hepatocellular carcinoma drug-resistant cells(HepG2/cDDP) on the expression of cytochrome P450

and detect whether ALR has relationship with the drug resistance of human hepatocellular carcinoma cells by affecting CYP540.Methods: A drug resistant human hepatoma cell line(HepG2/cDDP) induced by cisplatin was established in vitro

and its resistance index was evaluated by MTT assay.The expressing siRNA plasmid psiALR-A targeting hALR and the unrelated control plasmid psiALR-B were constructed successfully and transfected into HepG2/cDDP cells with lipofectamine 2000 methods

respectively;the expression of green fluorescent protein was observed under a fluorescence microscope to calculate transfection efficiency.According to different plasmid transfection

HepG2/cDDP cells were divided into three groups: transfection group(transfected psiALR-A)

control group(transfected psiALR-B)

and blank control group(non-transfected with the recombinant plasmid).The protein and mRNA level of hALR and CYP450 in each group of cells were measured by immunocytochemistry

Western Blot and Real-time FQ-PCR.The activities of CYP450 in each group of cells were detected by chemiluminescence;drug sensitivity to cDDP in each group cells was detected by MTT assay.Results: HepG2/cDDP cell line was established successfully with stable resistance to cDDP

and the resistance index(RI) was 6.26.Plasmid psiALR-A targeting hALR and the unrelated control plasmid psiALR-B were transfected successfully.In transfection group

the level of hALR protein and mRNA expression decreased significantly

but the level of CYP450 protein and mRNA expression increased significantly.In the control group and blank control group

there was no obvious change.The activities of CYP450 were increased significantly and the sensitivity to cDDP was decreased in transfection group;however

there was no obvious change in the control group and blank control group.Conclusion: The level of CYP450 expression and the activities of CYP450 are increased significantly

but the sensitivity to cDDP is decreased in transfection group.ALR may play an important role in the occurrence and development of the drug resistance of hepatocellular carcinoma cells.

关键词

肝再生增强因子CYP450肝癌顺铂药物耐受性RNA干扰

Keywords

augmenter of liver regenerationcytochrome P450hepatocellular carcinomacisplatindrug resistanceRNA interfe-rence

references

Views

187

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Promotion of the proliferation of hepatocellular carcinoma cells by acetyl-CoA carboxylase 2 through cell cycle regulation

Effect of Glycyrrhiza uralensis Fisch. endophytes combined with cisplatin on proliferation and apoptosis of A549 cells

Study on the sensitizing effect of SCR7 on cisplatin chemotherapy in triple-negative breast cancer

Inhibitory effect of dihydroartemisinin combined with cisplatin on the proliferation of bladder cancer cells

Quantification of intrahepatic cccDNA,DNA,serum HBV DNA and its relationship with HBeAg in hepatitis B virus-related hepatocellular carcinoma

Related Author

Zhang Zhirong

Wang Kai

Tang Ni

Zhang Shanglong

Zhang Nan

Lian Xiaolong

Ye Liqiao

Ma Quhuan

Related Institution

Key Laboratory of Molecular Biology of Infectious Diseases Designated by the Chinese Ministry of Education， Chongqing Medical University

College of Pharmacy，Gansu University of Chinese Medicine

Department of Internal Oncology，People's Hospital of Inner Mongolia Medical University

Teaching and Research Section of Immunology，School of Basic Medical Sciences，Inner Mongolia Medical University

Department of Urology，The Second Affiliated Hospital of Kunming Medical University，Yunnan Institute of Urology

⁰